Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
- PMID: 36033448
- PMCID: PMC9413079
- DOI: 10.3389/fonc.2022.971462
Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
Abstract
Matricellular proteins are nonstructural extracellular matrix components that are expressed at low levels in normal adult tissues and are upregulated during development or under pathological conditions. Tenascin C (TNC), a matricellular protein, is a hexameric and multimodular glycoprotein with different molecular forms that is produced by alternative splicing and post-translational modifications. Malignant gliomas are the most common and aggressive primary brain cancer of the central nervous system. Despite continued advances in multimodal therapy, the prognosis of gliomas remains poor. The main reasons for such poor outcomes are the heterogeneity and adaptability caused by the tumor microenvironment and glioma stem cells. It has been shown that TNC is present in the glioma microenvironment and glioma stem cell niches, and that it promotes malignant properties, such as neovascularization, proliferation, invasiveness, and immunomodulation. TNC is abundantly expressed in neural stem cell niches and plays a role in neurogenesis. Notably, there is increasing evidence showing that neural stem cells in the subventricular zone may be the cells of origin of gliomas. Here, we review the evidence regarding the role of TNC in glioma progression, propose a potential association between TNC and gliomagenesis, and summarize its clinical applications. Collectively, TNC is an appealing focus for advancing our understanding of gliomas.
Keywords: clinical significance; glioma progression; gliomagenesis; matricellular protein; neurogenesis; tenascin C.
Copyright © 2022 Fu, Zhu, Luo, Chen, Dou, Chen, Zhong, Su and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9413079/bin/fonc-12-971462-g006.gif)
Similar articles
-
Biology of Tenascin C and its Role in Physiology and Pathology.Curr Med Chem. 2024;31(19):2706-2731. doi: 10.2174/0929867330666230404124229. Curr Med Chem. 2024. PMID: 37021423 Review.
-
MicroRNA‑218 inhibits the malignant phenotypes of glioma by modulating the TNC/AKT/AP‑1/TGFβ1 feedback signaling loop.Int J Mol Med. 2021 Nov;48(5):205. doi: 10.3892/ijmm.2021.5038. Epub 2021 Sep 24. Int J Mol Med. 2021. PMID: 34558654 Free PMC article.
-
Tenascin-C Function in Glioma: Immunomodulation and Beyond.Adv Exp Med Biol. 2020;1272:149-172. doi: 10.1007/978-3-030-48457-6_9. Adv Exp Med Biol. 2020. PMID: 32845507 Review.
-
Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.Neuro Oncol. 2016 Apr;18(4):507-17. doi: 10.1093/neuonc/nov171. Epub 2015 Aug 27. Neuro Oncol. 2016. PMID: 26320116 Free PMC article.
-
ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.Neuro Oncol. 2015 Aug;17(8):1095-105. doi: 10.1093/neuonc/nou362. Epub 2015 Feb 1. Neuro Oncol. 2015. PMID: 25646025 Free PMC article.
Cited by
-
Mechanical characteristics of glioblastoma and peritumoral tumor-free human brain tissue.Acta Neurochir (Wien). 2024 Feb 23;166(1):102. doi: 10.1007/s00701-024-06009-x. Acta Neurochir (Wien). 2024. PMID: 38396016 Free PMC article.
-
Evaluating nanoparticle localisation in glioblastoma multicellular tumour spheroids by surface enhanced Raman scattering.Analyst. 2023 Jul 10;148(14):3247-3256. doi: 10.1039/d3an00751k. Analyst. 2023. PMID: 37366648 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous